Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient

Characteristics of a broad lytic spectrum endolysin from phage BtCS33 of Bacillus thuringiensis

(2012) Yihui Yuan et al.   BMC MICROBIOLOGY

Antibacterial properties of a pre-formulated recombinant phage endolysin, SAL-1

(2012) Soo Youn Jun et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparison of the Antibacterial Properties of Phage Endolysins SAL-1 and LysK

(2011) Soo Youn Jun et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antivenin-related Serum Sickness

(2010) Chin-Yuan Huang et al.   Journal of the Chinese Medical Association

Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection

(2009) Kazunori Murata et al.   Transplantation Reviews

Complement activation cascade and its regulation: Relevance for the response of solid tumors to photodynamic therapy

(2008) Mladen Korbelik et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY